Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects

Research output: Contribution to journalReviewResearchpeer-review

Standard

Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects. / Bergstrom, Christel A. S.; Box, Karl; Holm, Rene; Matthews, Wayne; McAllister, Mark; Mullertz, Anette; Rades, Thomas; Schaefer, Kerstin J.; Teleki, Alexandra.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 139, 06.2019, p. 101-114.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Bergstrom, CAS, Box, K, Holm, R, Matthews, W, McAllister, M, Mullertz, A, Rades, T, Schaefer, KJ & Teleki, A 2019, 'Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects', European Journal of Pharmaceutics and Biopharmaceutics, vol. 139, pp. 101-114. https://doi.org/10.1016/j.ejpb.2019.03.011

APA

Bergstrom, C. A. S., Box, K., Holm, R., Matthews, W., McAllister, M., Mullertz, A., ... Teleki, A. (2019). Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects. European Journal of Pharmaceutics and Biopharmaceutics, 139, 101-114. https://doi.org/10.1016/j.ejpb.2019.03.011

Vancouver

Bergstrom CAS, Box K, Holm R, Matthews W, McAllister M, Mullertz A et al. Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects. European Journal of Pharmaceutics and Biopharmaceutics. 2019 Jun;139:101-114. https://doi.org/10.1016/j.ejpb.2019.03.011

Author

Bergstrom, Christel A. S. ; Box, Karl ; Holm, Rene ; Matthews, Wayne ; McAllister, Mark ; Mullertz, Anette ; Rades, Thomas ; Schaefer, Kerstin J. ; Teleki, Alexandra. / Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects. In: European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; Vol. 139. pp. 101-114.

Bibtex

@article{d62e70d99e0d4ce19465593626cfac58,
title = "Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects",
author = "Bergstrom, {Christel A. S.} and Karl Box and Rene Holm and Wayne Matthews and Mark McAllister and Anette Mullertz and Thomas Rades and Schaefer, {Kerstin J.} and Alexandra Teleki",
year = "2019",
month = "6",
doi = "10.1016/j.ejpb.2019.03.011",
language = "English",
volume = "139",
pages = "101--114",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects

AU - Bergstrom, Christel A. S.

AU - Box, Karl

AU - Holm, Rene

AU - Matthews, Wayne

AU - McAllister, Mark

AU - Mullertz, Anette

AU - Rades, Thomas

AU - Schaefer, Kerstin J.

AU - Teleki, Alexandra

PY - 2019/6

Y1 - 2019/6

U2 - 10.1016/j.ejpb.2019.03.011

DO - 10.1016/j.ejpb.2019.03.011

M3 - Review

C2 - 30862481

VL - 139

SP - 101

EP - 114

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

ER -

ID: 227568225